engcon AB
SE0017769847 Short position disclosed on July 17, 2026.
1.44% of the capital sold short
2 disclosing funds
9 disclosures on record
Funds holding engcon AB Titelia
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
June 24, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPMorgan Asset Management (UK) Ltd | 0.76% | new | June 24, 2026 | |
| Qube Research & Technologies Limited | 0.68% | new | July 17, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 17, 2026 | Qube Research & Technologies Limited | 0.68% | still open |
| June 24, 2026 | JPMorgan Asset Management (UK) Ltd | 0.76% | still open |
| June 5, 2026 | JPMorgan Asset Management (UK) Ltd | 0.60% | still open |
| May 28, 2026 | Qube Research & Technologies Limited | 0.70% | still open |
| May 19, 2026 | Qube Research & Technologies Limited | 0.60% | still open |
| April 16, 2026 | Qube Research & Technologies Limited | 0.50% | still open |
| March 9, 2026 | JPMorgan Asset Management (UK) Ltd | 0.57% | still open |
| June 2, 2025 | Wellington Management International Limited | 0.52% | still open |
| June 24, 2024 | Otus Capital Management Limited | 0.52% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short